IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Bio Medica Laboratories IPO is a Book Building IPO listing on NSE SME exchange, with an ipo size of ₹ [●] Cr. The company is based in Indore and caters to Pharmaceutical sector. Narnolia Financial Services is the merchant banker of Bio Medica Laboratories IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th August 2025.
Bio Medica Laboratories IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
21.99 cr.
Sector: Pharmaceutical
SME
IPO so far:
40
Merchant Banker:
Narnolia Financial
SME
IPO by BRLM so far:
21
City:
Indore
SME
IPO so far:
19
Revenue (annualised):
₹
38.19
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 20.74x
Bio Medica Laboratories IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Narnolia Financial Services Limited is the book-running lead manager of the Bio Medica Laboratories IPO. Skyline Financial Services Private Limited is the Registrar for Bio Medica Laboratories IPO.
Bio Medica Laboratories IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Bio Medica Laboratories IPO, based in Indore, operates in the Pharmaceutical sector with a focus on manufacturing of pharmaceutical parenteral formulations. The company is launching its SME Upcoming IPO on the NSE SME exchange, using the Book Building Issue method. Bio Medica Laboratories IPO size is ₹ [●] with fresh issue size of ₹ 0 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Bio Medica Laboratories IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Bio Medica Laboratories IPO allotment status on the registrars website, Skyline Financial Services Private Limited . Bio Medica Laboratories IPO refund dates are [●].
Bio Medica Laboratories IPO is expected to be listed on [●].
The upper price band for the Bio Medica Laboratories IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Bio Medica Laboratories IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Bio Medica Laboratories IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Bio Medica Laboratories IPO is finalised.
The merchant banker for Bio Medica Laboratories IPO is Narnolia Financial Services Limited . Narnolia Financial Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Bio Medica Laboratories IPO RHP for further details.
The registrar for Bio Medica Laboratories IPO is Skyline Financial Services Private Limited . Investors can go to Skyline Financial Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Bio Medica Laboratories IPO through their official website or helpline.
Bio Medica Laboratories IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 21.99 Cr.
Sector: Pharmaceutical
SME
IPO so far:
40
Merchant Banker:
Narnolia Financial
SME
IPO by BRLM so far:
21
City:
Indore
SME
IPO so far:
19
Revenue (annualised):
₹ 38.19 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 20.74x
Bio Medica Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Bio Medica Laboratories Financial Review Page
Merchant Banker(s) of Bio Medica Laboratories IPO: Narnolia Financial Services Limited
Bio Medica Laboratories IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Bio Medica Laboratories IPO listed at a listing price of against the offer price of .
The current market price of Bio Medica Laboratories is .
Why Us?
